• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Keratoconjunctivitis

Keratoconjunctivitis - 40 Studies Found

Enrolling by invitation : An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
: Keratoconjunctivitis Sicca
: 2016-07-24
: Drug: OTX-101 0.09% 0.09% cyclosporine nanomicellar solution
Completed : Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
: Keratoconjunctivitis, Vernal
: 2006-07-26
: Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine)
Completed : Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca
: Keratoconjunctivitis Sicca
: 2013-03-21
:
  • Drug: Lotemax Gel + Restasis O

Completed : To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
: Keratoconjunctivitis Sicca
: 2013-07-11
:
  • Drug: R348 Ophthalmic Solution, 0.2%

Completed : A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
: Keratoconjunctivitis Sicca
: 2009-02-24
: Drug: voclosporin ophthalmic solution 0.02%, 0.2% t.i.d. or b.i.d.
Completed : Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
:
  • Keratoconjunctivitis
  • Conjunctivitis

: 2007-12-03
:
  • Drug: FK506 Opthalmic suspensi

Completed : Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
:
  • Keratoconjunctivitis Sicca
  • Dry Eye Syndrome

: 2013-02-21
: Drug: dexamethasone, artificial tears
Completed : Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
: Keratoconjunctivitis Sicca
: 2009-04-17
:
  • Dietary Supplement: Hydroeye 2

Completed : The Pathogenesis of Superior Limbic Keratoconjunctivitis
: Superior Limbic Keratoconjunctivitis
: 2005-09-12
Completed : Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
:
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease

: 2014-09-29
:
  • Drug: OTX-101 0.05% OTX-101 0.

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.